exemestane
SpainDrugs containing this active substance
-
It is used to treat hormone-dependent breast cancer in postmenopausal women, both in early stages (after completing 2-3 years of tamoxifen treatment) and in cases of advanced breast cancer when other hormonal treatments have not been effective.
Form: tablets, film-coated
Active substance Dosage exemestane 25 mg Manufacturer: Pfizer S.L.
-
It is used to treat hormone-dependent breast cancer in postmenopausal women. It can be used both in early-stage cancer (after completing 2 or 3 years of tamoxifen treatment) and in advanced breast cancer cases when other hormone treatments have not worked.
Form: tablets, film-coated
Active substance Dosage exemestane 25,00 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used to treat hormone-dependent breast cancer in postmenopausal women. It may be prescribed in early stages after completing 2-3 years of treatment with tamoxifen, or to treat advanced breast cancer when other hormonal treatments have not been effective.
Form: tablets, film-coated
Active substance Dosage exemestane 25 mg Manufacturer: Laboratorios Cinfa S.A.
-
It is used to treat hormone-dependent breast cancer in women who have already gone through menopause, both in cases of early breast cancer (after completing 2-3 years of treatment with tamoxifen) and in cases of advanced breast cancer when other hormonal treatments have not been effective.
Form: tablets, film-coated
Active substance Dosage exemestane 25 mg Manufacturer: Laboratorio Generfarma S.L.
-
It is used to treat hormone-dependent breast cancer in postmenopausal women, both in early stages (after completing 2-3 years of tamoxifen treatment) and in cases of advanced breast cancer when other hormonal treatments have not been effective.
Form: tablets, film-coated
Active substance Dosage exemestane 25,00 mg Manufacturer: Kern Pharma S.L.
-
It is used to treat early-stage hormone-dependent breast cancer in postmenopausal women who have already completed 2-3 years of tamoxifen treatment, as well as advanced breast cancer in postmenopausal women when other hormonal treatments have not been effective.
Form: tablets, film-coated
Active substance Dosage exemestane 25 mg Manufacturer: Laboratorios Normon S.A.
-
It is used to treat hormone-dependent breast cancer in postmenopausal women. It can be prescribed in early stages (after completing 2-3 years of tamoxifen treatment) or in cases of advanced breast cancer when other hormonal treatments have not been effective.
Form: tablets, film-coated
Active substance Dosage exemestane 25 MG mg Manufacturer: Sandoz Farmaceutica S.A.
-
It is used to treat early-stage hormone-dependent breast cancer in postmenopausal women who have already completed 2-3 years of treatment with tamoxifen. It is also used to treat advanced hormone-dependent breast cancer in postmenopausal women when other hormonal treatments have not been effective.
Form: tablets, film-coated
Active substance Dosage exemestane 25,00 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to treat early-stage hormone-dependent breast cancer in postmenopausal women who have already completed 2-3 years of treatment with tamoxifen. It is also used to treat advanced hormone-dependent breast cancer in postmenopausal women when other hormonal treatments have not been effective.
Form: tablets, film-coated
Active substance Dosage exemestane 25 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to treat early hormone-dependent breast cancer in women who have already gone through menopause and have completed 2 to 3 years of treatment with tamoxifen. It is also used for advanced hormone-dependent breast cancer in postmenopausal women when other hormonal treatments have not worked.
Form: tablets, film-coated
Active substance Dosage exemestane 25 mg Manufacturer: Viatris Limited
-
It is used to treat hormone-dependent breast cancer in postmenopausal women, both in early stages (after completing 2-3 years of tamoxifen treatment) and in cases of advanced breast cancer when other hormonal treatments have not been effective.
Form: tablets, film-coated
Active substance Dosage exemestane MG mg Manufacturer: Farmalider S.A.
-
It is used to treat hormone-dependent breast cancer in postmenopausal women. It may be prescribed in early stages after completing 2-3 years of tamoxifen treatment, or to treat advanced breast cancer when other hormonal treatments have not been effective.
Form: tablets, film-coated
Active substance Dosage exemestane 25 mg Manufacturer: Gp Pharm S.A.